| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8218268 | International Journal of Radiation Oncology*Biology*Physics | 2014 | 10 Pages |
Abstract
Cross-talk between the HIF2α and SHH-GLI1 pathways was demonstrated in RCC. Cotargeting these 2 pathways, significantly sensitizing RCC cells to IR, provides a novel strategy for RCC treatment.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Jiancheng PhD, Kaijie PhD, Dexuan PhD, Guodong PhD, Dapeng MD, Xinyang MS, Yule PhD, Yuefeng MD, Wenbin PhD, Zhenkun PhD, Craig MD, Debabrata PhD, Jer-Tsong PhD, Dalin MD,